Latest Financial Performance News

Dyno Nobel Limited reported a robust 23% increase in EBIT for FY25, driven by strong explosives performance and transformation initiatives, while progressing its fertilisers separation and setting ambitious sustainability targets.

Dyno Nobel reports a robust FY25 with a 23% rise in EBIT excluding major one-offs, nearing completion of its Fertilisers business separation and setting ambitious new decarbonisation targets.

Dyno Nobel reported a modest revenue dip but a solid 5.6% rise in net profit excluding one-off items for FY25, completing key divestments and advancing its transformation program.

Count Limited reported robust FY2025 financial results marked by significant revenue and profit growth, underpinned by strategic acquisitions and organic expansion. The positive momentum continues into FY2026 Q1 with further gains and a solid M&A pipeline.

NexGen Energy Ltd. reported a significant net loss for the nine months ended September 30, 2025, driven by mark-to-market losses on convertible debentures and impairment charges. The company bolstered its liquidity with a $953 million equity raise post-period.

Monadelphous Group Limited has raised its revenue guidance for 2025, buoyed by strong contract awards and elevated activity across its engineering and construction divisions.

News Corporation reported a 2% revenue increase to $2.144 billion for Q1 FY2026, driven by growth in Dow Jones and Digital Real Estate Services, while Book Publishing faced headwinds. Net income rose 4% to $150 million, supported by operational efficiencies and a robust balance sheet.

8I Holdings Limited has reported a remarkable 255% surge in net profit for the half-year ending September 2025, yet it has chosen not to declare any dividends. Investors are left weighing strong gains against cautious capital management.

ANZ Group Holdings reported a 10% decline in cash profit for FY2025 despite an 8% rise in operating income, maintaining its dividend amid significant restructuring and regulatory costs.

Epsilon Healthcare reports a strong rebound with a 73% revenue increase in the June quarter, driven by contract manufacturing and new pharmacy operations. The company is emerging from restructuring with renewed financial strength and growth prospects.

Epsilon Healthcare has commenced operations of its new pharmacy division and extended a key loan facility, signaling a strategic pivot towards integrated healthcare and financial stability after recent restructuring.

Macquarie Group reported a 3% rise in net profit to A$1.655 billion for the half year ended September 2025, driven by strong growth in asset management and capital divisions. The group also extended its A$2 billion share buyback program and declared a solid interim dividend.